In the esteemed 2022 Targeted Therapies Forum, Dr. Jia Luo, renowned Medical Oncologist from Dana-Farber Cancer Institute and respected Instructor in Medicine at Harvard, alongside Dr. Isabel Preeshagul, Thoracic Medical Oncologist from Memorial Sloan Kettering, dives deep into the realm of KRAS Treatments and Clinical Trials. Specifically, Dr. Jia Luo sheds light on the treatment pathways for KRAS+ NSCLC and provides insights on navigating the complex landscape of clinical trials.
Grateful for the support from our sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech.
To explore more on the latest cancer treatments and engage with a vibrant community, do visit http://cancerGRACE.org/. For expert discussions and peer interactions, head over to https://cancergrace.org/forum.